DE602005016231D1 - Amorolfin-pflaster zur behandlung von onychomykose - Google Patents

Amorolfin-pflaster zur behandlung von onychomykose

Info

Publication number
DE602005016231D1
DE602005016231D1 DE602005016231T DE602005016231T DE602005016231D1 DE 602005016231 D1 DE602005016231 D1 DE 602005016231D1 DE 602005016231 T DE602005016231 T DE 602005016231T DE 602005016231 T DE602005016231 T DE 602005016231T DE 602005016231 D1 DE602005016231 D1 DE 602005016231D1
Authority
DE
Germany
Prior art keywords
absorption
treatment
onychomycosis
amorolfine
patch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005016231T
Other languages
English (en)
Inventor
Leslie Zanutto
Laurent Chemin Du Camouyer Fredon
Claire Mallard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Publication of DE602005016231D1 publication Critical patent/DE602005016231D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Saccharide Compounds (AREA)
DE602005016231T 2004-03-29 2005-03-23 Amorolfin-pflaster zur behandlung von onychomykose Active DE602005016231D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0403206A FR2867978B1 (fr) 2004-03-29 2004-03-29 Patch d'amorolfine pour le traitement de l'onychomicose
PCT/FR2005/000704 WO2005092299A1 (fr) 2004-03-29 2005-03-23 Patch d’amorolfine pour le traitement de l’onychomycose

Publications (1)

Publication Number Publication Date
DE602005016231D1 true DE602005016231D1 (de) 2009-10-08

Family

ID=34945085

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016231T Active DE602005016231D1 (de) 2004-03-29 2005-03-23 Amorolfin-pflaster zur behandlung von onychomykose

Country Status (8)

Country Link
US (2) US20070104772A1 (de)
EP (1) EP1732525B1 (de)
AT (1) ATE440596T1 (de)
CA (1) CA2558513C (de)
DE (1) DE602005016231D1 (de)
ES (1) ES2330453T3 (de)
FR (1) FR2867978B1 (de)
WO (1) WO2005092299A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2892023B1 (fr) * 2005-10-14 2009-09-25 Galderma Sa Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
DE102008006791B4 (de) * 2008-01-30 2011-11-24 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit Harnstoff-Komponente und Verfahren zu dessen Herstellung
NL1036661C2 (en) 2009-03-04 2010-09-07 Serrix B V Anti-fungal compounds & compositions.
NL2003786C2 (en) * 2009-11-11 2010-07-30 Medner B V COMPOSITION FOR TOPICAL APPLICATION, USES THEREOF, APPLICATOR DEVICE AND KIT OF PARTS.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
US6271240B1 (en) * 1996-05-06 2001-08-07 David Lew Simon Methods for improved regulation of endogenous dopamine in prolonged treatment of opioid addicted individuals
US6727401B1 (en) * 1998-02-12 2004-04-27 Watson Pharmaceuticals, Inc. Pressure sensitive adhesive matrix patch for the treatment of onychomycosis
JP2003508424A (ja) * 1999-08-31 2003-03-04 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 真菌成長培地を用いる真菌感染の治療
EP1263426B1 (de) * 2000-01-03 2006-03-15 Karl Kraemer Zubereitungen zur atraumatischen nagelentfernung
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same
NZ531404A (en) * 2001-09-04 2006-03-31 Trommsdorff Gmbh & Co Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
CN1703206A (zh) * 2001-09-04 2005-11-30 泰姆斯多夫药品有限公司 治疗指甲生长功能紊乱失调的膏药
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails
JP2005538156A (ja) * 2002-09-05 2005-12-15 ガルデルマ・ソシエテ・アノニム 爪塗布用溶液

Also Published As

Publication number Publication date
WO2005092299A1 (fr) 2005-10-06
ATE440596T1 (de) 2009-09-15
EP1732525A1 (de) 2006-12-20
CA2558513C (fr) 2014-02-11
US20110218506A1 (en) 2011-09-08
ES2330453T3 (es) 2009-12-10
EP1732525B1 (de) 2009-08-26
CA2558513A1 (fr) 2005-10-06
FR2867978B1 (fr) 2009-02-20
FR2867978A1 (fr) 2005-09-30
US20070104772A1 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
ATE369825T1 (de) Wundauflage
DE59803647D1 (de) Transdermales therapeutisches system mit haftklebender reservoirschicht und unidirektional elastischer rückschicht
WO2007044647A3 (en) Pressure bandage with medication delivery system
DE602007010735D1 (de) Beschichtung mit polymerhaftmaterial für eine mediür
NZ306249A (en) matrix patch containing triacetin as a transdermal pentration enhancer
WO2005079675A3 (en) Medical devices and methods for applying bolster material
JP2007512924A5 (de)
DK1450740T3 (da) Sårforbinding
ES2118535T3 (es) Parche que contiene un principio activo.
CL2004000467A1 (es) Uso de un anticuerpo contra la subunidad p19 de interleuquina 23 (il-23), para preparar una composicion para el tratamiento de cnacer o de tumores. ]
DE602005016231D1 (de) Amorolfin-pflaster zur behandlung von onychomykose
BRPI0415850A (pt) composição de dna estabilizado para o revestimento de micro projeções
ATE410996T1 (de) Methoden zur behandlung von nägeln
ATE287262T1 (de) Transdermales arzneistoffverabreichungssystem
ATE163854T1 (de) Dexpanthenol-haltiges pflaster zur transdermalen applikation von steroidhormonen
ATE396714T1 (de) Transdermales therapeutisches system mit verbessertem langzeittragekomfort
ATE548023T1 (de) Zusammensetzungen, enthaltend proteine zum transfer / recycling strukturell veränderter lipide sowie deren anwendungen
HUP0204448A2 (en) Trnasdermal therapeutic system for the delivery of lerisetron
BRPI0704914A (pt) composição desodorante, dispositivo aerossol, uso do ácido salicìlico e método para tratar os odores axilares humanos
YU58998A (sh) Naprava za lokalno lečenje bubuljica i postupak za njenu izradu
ATE437634T1 (de) Transdermale abgabevorrichtung für dihydropyridin-artige calcium-antagonisten mit 2 fettsäuren
SE0103276L (sv) Anordning för administrering av salva till en hudyta
CL2004000884A1 (es) Composicion farmaceutica en forma de hidrogel que contiene un diester de acido carbonico, un alquilalcohol c2-c4, por lo menos una sustancia activa y una matriz de polimero; uso en el tratamiento de carencias esteroidales.
ATE294811T1 (de) Antisense-modulation von x-verbundenen inhibitoren der apoptosis-expression
CA2370023A1 (en) Transdermal therapeutic system with a highly effective neuroleptic agent

Legal Events

Date Code Title Description
8364 No opposition during term of opposition